Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recovery-focused Acceptance and Commitment Therapy Combined With Ketamine (K-ACT) for Patients With Difficult-to-treat Depression: a Feasibility Study.

NCT07906496 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT07906496 Not yet recruiting Not applicable 50 participants (estimated) Started 2027 1 site

Follow this trial by email Email me the PDF

Get the NCT07906496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started January 2027. Interventional study, 50 participants (estimated). Lead sponsor University of British Columbia; Canada. Primary measures: Feasibility outcomes; Safety outcomes.

How it compares

1,166 similar trials: same condition (Major Depressive Disorder) and phase

Enrollment

This trial
50
Middle half
34 to 139
Median
70
Trials with a value
1,163

Months from start to completion

This trial
17
Middle half
18 to 47.4
Median
30.9
Trials with a value
1,157

Sites

This trial
1
Middle half
1 to 1
Median
1
Trials with a value
1,089
Posted results or a linked paper 50% 579 of 1,166 similar trials; this trial: no

Registry record

As filed in ClinicalTrials.gov.

Title
Recovery-focused Acceptance and Commitment Therapy Combined With Ketamine (K-ACT) for Patients With Difficult-to-treat Depression: a Feasibility Study.
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
June 30, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

MeSH condition names; the registry's own terms follow.

Major Depressive Disorder

Registry terms: major depressive disorder (mdd)

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
All
Minimum age
18 Years
Healthy volunteers
No
Study type
Interventional
Sites
1
Countries
Canada
Lead sponsor
University of British Columbia

Arms

As registered; 1 arm.

Registered arms
Arm Type Interventions
K-ACT Intervention Experimental K-ACT Intervention

Primary endpoints

Registered primary outcome measures; 2 primary.

Registered primary endpoints
Measure Time frame
Feasibility outcomes 18 months/end of study
Show registry wording

Rate of recruitment/total participants enrolled, treatment attendance (sessions attended), retention, and follow-up completion

Safety outcomes 18 months/end of study
Show registry wording

Participant safety will be monitored through routine clinical assessments, including ongoing evaluation of suicidality and adverse events.

Lead sponsor's other trials

University of British Columbia, most recent start first.

Similar trials

Same condition (Major Depressive Disorder) and phase, most recent start first.